Phase I and Randomized Phase II Study of Ruxolitinib with Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: an NRG Oncology Group Study
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2024)